polymorphism and panic whom met DSM-III-R 15 criteria for PD. Information on the patients' symptoms of panic attacks and related disorder psychiatric symptoms was obtained by one of the authors in face-to-face semistructured interviews. The SIR -Family studies [1] [2] [3] and a twin study 4 have shown control group consisted of 213 unrelated Japanese (96 the highly familial nature of panic disorder (PD) and males and 117 females, mean age 37.7 ± 13.1 years). suggested a genetic etiology. Genetic risk for PD has Informed consent was obtained from all subjects. been suggested by, for example, a CO 2 challenge study Genotyping of the 5-HTT regulatory region polymorindicating that hypersensitivity to CO 2 might identify phism was performed by PCR, a slight modification of a group of patients with high vulnerability to PD. 5 the method of Lesch et al 12 in which the concentration Another challenge study using m-chloro-phenyl-pipof dNTPs was 150 mol L −1 and 75% of dGTP was erazine (mCPP), a serotonin (5-HT) agonist, provided replaced with 7-deazaguanosine. Differences in allele evidence for serotonergic hyperactivity in PD. 6 The frequencies were tested for significance using the chiefficacy of selective serotonin reuptake inhibitors in square test. PD 7 supported this view. However, investigations of Table 1 shows the distribution of 5-HTTLPR geno-PD genetic linkage and association studies have been types in the two groups. In control samples, the S and few, and little is known about the candidate genes L allele frequencies were 77% and 23%, respectively, for PD. whereas a previous study had reported the frequencies The 5-HT transporter (5-HTT) plays a critical role in of the S and L alleles of 5-HTTLPR as 57% and 43% the termination of serotonergic neurotransmission by for 505 healthy Caucasians. 12 Comparison of these data sodium-dependent uptake of 5-HT into the presynaptic shows that the overall frequency of the L allele was neuron. Platelet-binding studies have suggested dysrelower in our Japanese samples; however, the genotype gulation of 5-HTT function in PD, 8, 9 and the V max of 5-distribution was in Hardy-Weinberg equilibrium, HT uptake in platelets has been indicated to be herihence the discrepancy could be attributed to ethnic diftable. 10 Recently, Heils et al found a 44-base pair (bp) ferences between Japanese and Caucasians. As shown deletion in the 5′-flanking regulatory region of the 5-in the table, the 5-HTTLPR genotype and allele fre-HTT gene and showed reduced activity of the 5-HTT quencies did not differ significantly (genotype, promoter with the deletion. 11 Using the NEO person-2 = 3.156, P Ͼ 0.1; allele, 2 = 1.987, P Ͼ 0.1) between ality inventory (NEO-PI-R), the Tridimensional Person-PD and controls. ality Questionnaire (TPQ), and Cattell's 16PF personBecause one study indicated that age at onset of PD ality inventory, Lesch et al found that a short (S) allele might reflect genetic penetrance, 16 we divided our subwith a deletion in this 5-HTT gene-linked polymorphic jects into two groups by age at onset, which we could region (5-HTTLPR) was significantly associated with a identify for 85 of 86 PD patients. Using Feighner's crihigh score on neuroticism or anxiety in a healthy poputeria, 17 we defined late-onset patients as those whose lation. 12 They showed that individuals with this short age at onset was Ն40 years and those Ͻ40 years old as 5-HTTLPR allele and reduced 5-HTT function have early-onset. However, neither the 5-HTTLPR genotype more anxiety-related personality characteristics. In nor allele frequencies differed significantly between earlier studies, patients with PD had higher neurotithese age groups (genotype, 2 = 0.668, P Ͼ0.1; allele, cism scores on the NEO personality inventory 13 and 2 = 0.348, P Ͼ 0.1). higher scores on the harm avoidance dimension in the TPQ scores. 14 In summary, this case-control examination suggests 2,4,5 I had written a review of bipolar linkage studies 6 in which I expressed the opinion that it plain that the candidate segment defined by haplotype sharing in their data in 18q23 'does not appear to the 18q21 region of interest identified by Stine et al 2 was probably the same locus identified by Freimer et overlap' with the 18q21 region identified by Stine et al. 2 Berrettini argues further that a subsequent report al 3 at 18q22-3. In essence, I wrote then 6 and now affirm that, in my opinion, there are two confirmed 7 bipolar by Freimer's group 4 also suggests 'that there is substantial overlap between the Stine et al 2 locus and their susceptibility loci on 18, one near 18q22 2, 3, 8 and the other near the centromere on 18. 2, 4, 5, 9, 10 locus'. In fact, this is what the investigators themselves 4 had to say about this matter: 'The cluster of Baron 1 mistakenly attributes to me (referencing my suggestive lod scores in 18q22-q23 is adjacent to, but includes both arms of chromosome 18'. The difficulties in reconciling the various statements made on this matdoes not appear to overlap with, a possible localization to 18q21'. Further, the 10-20 cM map distance attriter by some of the researchers who advocate bipolar disease loci on chromosome 18 were also noted by buted by Berrettini to the interval between the region identified by Freimer et al at 18q22-q23 and the locus other investigators. 8 Finally, Berrettini concludes that there are now 'conidentified by Stine et al 18q21-using the BRCA1 locus as an analogy, Berrettini argues that this discrepancy firmed bipolar susceptibility loci' on chromosome 18, including the region identified by his group. In my may well be due to difficulties in localizing complex disease genes-is inaccurate. Recent maps of this recent review, 1 I cautioned, on statistical and other grounds, against premature claims of confirmed loci. chromosomal region 5 indicate that the actual distance between the implicated regions is far greater, making a Independent replication of the initial findings is onearguably the most crucial-prerequisite to declaring a convergence of the two putative loci even less likely.
Berrettini is correct in pointing out that his recent particular finding 'confirmed'. The linkage evidence in the replication attempts deemed by Berrettini 'conreview 6 does not state that all the reports on bipolar disorder and chromosome 18 (ie, the pericentromeric firmatory' is far from compelling. Moreover, Berrettini curiously omits references to other studies, which were region, 18q21, and 18q22-q23) identify the same locus-only those pertaining to regions 18q21 and based on substantially larger samples-and are therefore statistically more meaningful than the smaller 18q22-q23 which, as I have demonstrated in the preceding paragraph and elsewhere, 1 is far from clear. pedigree series-but failed to confirm the purported linkage. [9] [10] [11] [12] However, statements made elsewhere by Berrettini and others suggest, quite improbably, that the genetic span In conclusion, it remains to be seen if any of the implicated loci on chromosome 18 will bear fruit. With implicated is even larger, apparently covering most of the chromosome. Specifically, in analyzing their data uncertainties abound in several key areas such as genetic distances, statistical significance, and replication, according to parent-of-origin effect, Berrettini's group 7 reported that pedigrees with paternal (as opposed to claims to the contrary should be treated with caution. maternal) transmission were preferentially linked to chromosome 18 pericentromeric markers. They con
